External preparation for treating corticosteroid-dependent dermatitis

A technology for dependent dermatitis and topical preparations, applied in the direction of medical preparations containing active ingredients, skin diseases, plant raw materials, etc., can solve the problems of unsatisfactory treatment effects, low overall cure rate, long treatment cycle, etc., to promote Skin cell metabolism, no toxic side effects, definite curative effect

Active Publication Date: 2015-07-22
温军海
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Even so, the traditional treatment effect is not particularly ideal, the treatment cycle is

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External preparation for treating corticosteroid-dependent dermatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] The external preparation for treating hormone-dependent dermatitis in this example is composed of the following proportions by weight: 10 parts of peony root extract; 10 parts of comfrey extract; 5 parts of licorice extract; 100 parts of witch hazel extract; Snow lotus flower extract 5 parts; Astragalus extract 5 parts; Borneol 1 part; Glycerin: 5 parts; Bisabolol 10 parts; Allantoin: 1 part; Vitamin B3: 10 parts; 10 parts; L-vitamin C: 5 parts; L-glutamic acid: 10 parts.

Embodiment 2

[0012] The external preparation for treating hormone-dependent dermatitis in this embodiment is composed of the following proportions by weight: 40 parts of peony root extract; 40 parts of comfrey extract; 20 parts of licorice extract; 40 parts of witch hazel extract; Snow lotus extract 10 parts; Astragalus extract 40 parts; Borneol 3 parts; Glycerin: 20 parts; Bisabolol 20 parts; Allantoin: 10 parts, Vitamin B3: 40 parts; 20 parts; L-vitamin C: 20 parts; L-glutamic acid: 40 parts;

Embodiment 3

[0014] The external preparation for treating hormone-dependent dermatitis in this example is composed of the following proportions by weight: 40 parts of peony root extract; 40 parts of comfrey extract; 10 parts of licorice extract; 20 parts of witch hazel extract; 10 parts of snow lotus extract; 40 parts of astragalus extract; 1 part of borneol; 10 parts of glycerin; 10 parts of bisabolol; 10 parts of allantoin; 40 parts of vitamin B3; 20 parts; L-vitamin C: 5 parts; L-glutamic acid: 40 parts.

[0015] Embodiment effect:

[0016] Through 8 weeks of regular observation and follow-up of 162 test subjects with hormone-dependent dermatitis, the use of 10-40 parts of peony root extract; 10-40 parts of comfrey extract; 5-20 parts of licorice extract; witch hazel extract 10-40 parts; 5-10 parts of snow lotus extract; 5-30 parts of astragalus extract; 1-3 parts of borneol; 5-20 parts of glycerin; 10-20 parts of bisabolol; vitamin B3: 10-40 parts; vitamin B2: 1-10 parts; vitamin E: ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an external preparation for treating corticosteroid-dependent dermatitis. The external preparation is prepared from the following crude drugs in parts by weight: 10-40 parts of peony root extract, 10-40 parts of lithospermum extract, 5-20 parts of radix glycyrrhizae extract, 10-40 parts of witch hazel extract, 5-10 parts of snow lotus herb extract, 5-30 parts of astragalus extract, 1-3 parts of borneol, 5-20 parts of glycerol, 10-20 parts of bisabol, 1-10 parts of allantoin, 10-40 parts of vitamin B3, 1-10 parts of vitamin B2, 10-20 parts of vitamin E, 5-20 parts of L-vitamin C and 10-40 parts of L-glutamic acid. In the formula, the external preparation does not contain glucocorticoid substances and antibiotics, and is free of dependency after long-term use, can also be suitable for psoriasis, tinea capitis, tinea corporis, tinea of feet and hands and the like caused by acnes, acne-like dermatitis, various eczemas, acute and chronic dermatitis, acarid dermatitis and funguses, is free of toxic or side effects, high in safety in clinical use and high in healing rate.

Description

technical field [0001] The invention relates to the technical field of dermatitis preparations, in particular to an external preparation for treating hormone-dependent dermatitis. Background technique [0002] There are two major causes of hormone-dependent dermatitis: the first is hormone-dependent dermatitis caused by long-term abuse of therapeutic drugs in patients with chronic skin diseases. Patients pursue the rapid onset of drugs when treating facial skin diseases, which leads to facial glucocorticoid dependence. The occurrence of dermatitis is on the rise, which is a relatively traditional cause of the disease; the second is that in recent years, many beauty lovers have used cosmetics with functions such as freckle removal, whitening, anti-wrinkle, skin rejuvenation, acne removal, and anti-allergy. Unscrupulous merchants add glucocorticoids to cosmetics and beauty care products in order to pursue rapid product effects, especially the rapid development of the Internet,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/71A61P17/00
Inventor 段丽杰温军海
Owner 温军海
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap